First mitochondrial genome-wide association study with metabolomics

Area of Science:

• Genetics
• Metabolomics
• Personalized Medicine

Background:

• Metabolomics shows promise for disease diagnosis and prognosis.
• Mitochondrial DNA (mtDNA) mutations are linked to aging and age-related diseases.
• Understanding mtDNA's role in metabolic regulation is crucial for disease research.

Purpose of the Study:

• To investigate the association between mitochondrial nucleotide variants (mtSNVs) and metabolite concentrations.
• To identify genetic variants influencing metabolite profiles using an inverted genome-wide association analysis.
• To explore the interconnection between mitochondria and metabolite concentrations in complex diseases.

Main Methods:

• Performed an inverted mitochondrial genome-wide association analysis.
• Analyzed whole mitochondrial genomes and 151 metabolite concentrations from 2718 individuals.
• Utilized next-generation sequencing for accurate detection of mitochondrial heteroplasmy and variants.

Main Results:

• Identified significant associations between specific mtSNVs and metabolite ratios.
• The strongest association was between mt715G>A (MT-12SrRNA) and the C2/C10:1 metabolite ratio (P=6.82*10-09).
• Other significant associations involved mt3714A>G (MT-ND1) with phosphatidylcholine ratios and mt10689G>A (MT-ND4L) with PC aa C36:6.

Conclusions:

• Established a significant interconnection between mitochondria and metabolite concentrations.
• These findings may offer crucial insights into the pathogenesis of complex diseases like neurological and metabolic disorders.
• Understanding these genetic-metabolic interactions is vital for developing effective therapies for complex conditions.